Scarica l'app Stockscreener
5.31
11.02%
0.56
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVRX Giù?
Forum
Previsione
Precedente Chiudi:
$4.75
Aprire:
$4.9
Volume 24 ore:
756.13K
Relative Volume:
2.25
Capitalizzazione di mercato:
$202.82M
Reddito:
$47.26M
Utile/perdita netta:
$-58.48M
Rapporto P/E:
-1.9631
EPS:
-2.7049
Flusso di cassa netto:
$-40.45M
1 W Prestazione:
-29.03%
1M Prestazione:
-15.36%
6M Prestazione:
-62.86%
1 anno Prestazione:
-31.43%
Intervallo 1D:
$4.825
$5.33
Intervallo di 1 settimana:
$4.2993
$7.91
Portata 52W:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Nome
Cvrx Inc
Settore
Industria
Telefono
(763) 416-2850
Indirizzo
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Confronta CVRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
5.32 | 202.82M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
129.51 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.77 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.71 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.21 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.88 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Reiterato | Lake Street | Buy |
| 2024-05-01 | Ripresa | Craig Hallum | Buy |
| 2024-05-01 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Iniziato | Lake Street | Buy |
| 2022-07-18 | Iniziato | Craig Hallum | Buy |
| 2021-07-26 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-26 | Iniziato | Piper Sandler | Overweight |
| 2021-07-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Cvrx Inc Borsa (CVRX) Ultime notizie
CVRx CEO Makes Bold Investment Move! - TipRanks
Insider Buying: Kevin Hykes Acquires Additional Shares of CVRx I - GuruFocus
(CVRX) Trading Advice - news.stocktradersdaily.com
CVRx, Inc. (NASDAQ:CVRX) Q1 2025 Earnings Call Transcript - Insider Monkey
JPMorgan cuts CVRx stock rating, slashes price target to $7 By Investing.com - Investing.com India
CVRx (CVRX) Sees Downgrade and Price Target Reduction from JP Mo - GuruFocus
CVRx Earnings Call: Growth Amidst Challenges - TipRanks
CVRx (CVRX) Shares Fall Following Q1 Sales Miss and Downgrade - GuruFocus
CVRx price target lowered to $12 from $20 at Piper Sandler - TipRanks
JPMorgan cuts CVRx stock rating, slashes price target to $7 - Investing.com
CVRx stock downgraded at J.P. Morgan on Q1 miss (CVRX:NASDAQ) - Seeking Alpha
Demystifying CVRx: Insights From 4 Analyst Reviews - Benzinga
CVRx (CVRX) Target Price Lowered by Piper Sandler | CVRX Stock N - GuruFocus
Analysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and CVRx (CVRX) - The Globe and Mail
Investors Appear Satisfied With CVRx, Inc.'s (NASDAQ:CVRX) Prospects As Shares Rocket 25% - simplywall.st
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga
This International Paper Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
JPMorgan Downgrades CVRx to Underweight From Neutral, Adjusts Price Target to $7 From $15 - marketscreener.com
Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
CVRx Q1 2025 revenue increases 15% to USD 12.3 million - Medical Buyer
CVRx: Q1 Earnings Snapshot - New Haven Register
CVRx downgraded to Underweight from Neutral at JPMorgan - TipRanks
CVRx Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CVRx Q1 2025 shows improved EPS, stock dips - Investing.com Nigeria
CVRx Inc (CVRX) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Sales Force Realignment ... By GuruFocus - Investing.com Canada
CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
CVRx Reports First Quarter 2025 Financial and Operating Results - GlobeNewswire
CVRx Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CVRx, Inc. Reports Revenue Growth in Q1 2025 - TipRanks
What To Expect From CVRx Inc (CVRX) Q1 2025 Earnings - Yahoo Finance
Renaissance Technologies LLC Purchases Shares of 40,200 CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx Inc (CVRX) Is A Possible Investment At Current Levels - Stocksregister
CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
(CVRX) Proactive Strategies - news.stocktradersdaily.com
CVRX: Upcoming Conference Call to Explore Barostim and Heart Fai - GuruFocus
CVRx Inc Inc. (CVRX) Price Performance: The Role of Supply and Demand - investchronicle.com
$CVRX stock is up 8% today. Here's what we see in our data. - Nasdaq
Geode Capital Management LLC Has $4.11 Million Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
CVRx, Inc. to Announce Q1 2025 Financial Results on May 8, 2025 - Nasdaq
CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025 - GlobeNewswire
Russell Investments Group Ltd. Invests $455,000 in CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx Sets Q1 2025 Earnings Release: Key Financial Updates Coming May 8How to Join Live - Stock Titan
CVRx, Inc. (NASDAQ:CVRX) Shares Sold by Alliancebernstein L.P. - Defense World
Buying CVRx Inc (NASDAQ: CVRX)? Here Are Some Things To Consider - Stocksregister
CVRx, Inc. (NASDAQ:CVRX) Shares Acquired by JPMorgan Chase & Co. - Defense World
CVRx, Inc. (NASDAQ:CVRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
(CVRX) Investment Analysis - news.stocktradersdaily.com
Cantor maintains CVRx stock with $20 target despite revenue miss By Investing.com - Investing.com India
Cantor maintains CVRx stock with $20 target despite revenue miss - Investing.com Australia
Cvrx Inc Azioni (CVRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):